Research output per year
Research output per year
Personal profile
Education/Academic qualification
Master in Science, Allergy, Imperial College London
Award Date: 1 May 2017
Doctor of Philosophy, PhD, University of Glasgow
Award Date: 1 Apr 2009
Bachelor of Medicine and Bachelor of Surgery, University of Glasgow
Award Date: 2 Aug 2000
Bachelor of Science, Neuroscience, University of Glasgow
Award Date: 16 Jul 1997
External positions
Consultant, NHS Tayside
1 Mar 2021 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Mark Spears is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury
Stewart, I. (Lead / Corresponding author), Jacob, J., Porter, J. C., Liu, B., Tatler, A. L., Gomez, N., Pugh, M. R., John, A. E., Allen, R. J., Blaikley, J. F., Chaudhuri, N., Denneny, E., Fabbri, L., George, P. M., Guillen-Guio, B., Gooptu, B., Hall, I. P., Ho, L. P., Jarrold, I. & Johnson, S. & 31 others, , Feb 2026, In: EBioMedicine. 124, p. 1-14 14 p., 106134.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Link opens in a new tab Citation (Scopus)21 Downloads (Pure) -
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 Study
PHOSP-COVID Collaborative Group, Stewart, I. (Lead / Corresponding author), Jacob, J., George, P. M., Molyneaux, P. L., Porter, J. C., Allen, R. J., Aslani, S., Baillie, J. K., Barratt, S. L., Beirne, P., Bianchi, S. M., Blaikley, J. F., Chalmers, J. D., Chambers, R. C., Chaudhuri, N., Coleman, C., Collier, G., Denneny, E. K. & Docherty, A. & 31 others, , 15 Mar 2023, In: American Journal of Respiratory and Critical Care Medicine. 207, 6, p. 693-703 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile121 Link opens in a new tab Citations (Scopus)200 Downloads (Pure) -
A Randomized Double-Blind Placebo-Controlled Trial of Dipeptidyl Peptidase-1 Inhibition in Hospitalized Patients with COVID-19: The STOP-COVID19 Trial
Keir, H. R. (Lead / Corresponding author), Long, M. B., Abo leyah, H., Giam, Y. H., Vadiveloo, T., Pembridge, T., Hull, R., Delgado, L., Band, M., Mclaren-Neill, F., Adamson, S., Lahnsteiner, E., Gilmour, A., Hughes, C., New, B. J. M., Connell, D., Dowey, R., Turton, H., Richardson, H. & Cassidy, D. & 18 others, , 2 May 2022, p. A5055-A5055. 1 p.Research output: Contribution to conference › Paper › peer-review
-
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Abo-Leyah, H., Chalmers, J., Loftus, H. & Spears, M., 8 Jan 2022, In: Lancet. 399, 10320, p. 143-151 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile249 Link opens in a new tab Citations (Scopus)248 Downloads (Pure) -
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Keir, H. R., Long, M. B., Abo-leyah, H., Giam, Y. H., Vadiveloo, T., Pembridge, T., Hull, R. C., Delgado, L., Band, M., McLaren-Neil, F., Adamson, S., Lahnsteiner, E., Gilmour, A., Hughes, C., New, B. J., Connell, D., Dowey, R., Turton, H., Richardson, H. & Cassidy, D. & 20 others, , 1 Dec 2022, In: The Lancet Respiratory Medicine. 10, 12, p. 1119-1128 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile20 Link opens in a new tab Citations (Scopus)188 Downloads (Pure)